# Cardiac Output Monitoring to Predict Pre-Eclampsia and Restricted Growth (COMPaRE)

> **NCT05123677** · — · UNKNOWN · sponsor: **Sandwell & West Birmingham Hospitals NHS Trust** · enrollment: 200 (estimated)

## Conditions studied

- Fetal Growth Retardation
- Pre-Eclampsia

## Interventions

- **DIAGNOSTIC_TEST:** Non-invasive haemodynamic assessment
- **DIAGNOSTIC_TEST:** Maternal ophthalmic artery doppler

## Key facts

- **NCT ID:** NCT05123677
- **Lead sponsor:** Sandwell & West Birmingham Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05123677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05123677, "Cardiac Output Monitoring to Predict Pre-Eclampsia and Restricted Growth (COMPaRE)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05123677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*